US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.280
  • +0.342+36.46%
Close Dec 20 16:00 ET
  • 1.240
  • -0.040-3.13%
Post 19:59 ET
56.27MMarket Cap-0.83P/E (TTM)

About Xilio Therapeutics Company

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Company Profile

SymbolXLO
Company NameXilio Therapeutics
Listing DateOct 22, 2021
Issue Price16.00
Founded2015
CEODr. Rene Russo, Pharm.D.
MarketNASDAQ
Employees73
Fiscal Year Ends12-31
Address828 Winter Street,Suite 300
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-857-524-2466
Websitehttp://www.xiliotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Rene Russo, Pharm.D.
  • Director, Chief Executive Officer and President
  • 3.00M
  • Christopher Frankenfield
  • Chief Operating Officer
  • 1.86M
  • Dr. Katarina Luptakova, M.D.
  • Chief Medical Officer
  • 932.17K
  • Kevin M. Brennan
  • Senior Vice President, Finance and Accounting, Principal Financial Officer and Principal Accounting Officer
  • --
  • Paul J. Clancy
  • Chairman of the Board
  • 96.77K
  • James Shannon, M.D.
  • Director
  • --
  • Dr. Yuan Xu, PhD
  • Director
  • 65.77K
  • Tomas J. Heyman
  • Director
  • 77.27K
  • Dr. Aoife Brennan, M.D.
  • Director
  • --
  • Robert Ross
  • Director
  • 66.77K
  • Daniel Curran
  • Independent Director
  • --
  • Sara M. Bonstein
  • Independent Director
  • 76.77K
  • Christina Rossi, M.B.A.
  • Independent Director
  • 78.05K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%